NDC Compounded Drug 82396-141-05 Labetalol Hydrochloride
Injection, Solution Intravenous
Compounded Drug Product Information
NDC Crossover Products Matching Labetalol Hydrochloride
NDC crossover of Labetalol Hydrochloride with NDC 82396-141 a human compounded drug with other similar products matching the same substance name (Labetalol Hydrochloride) and the same administration route (intravenous) or dosage form (injection, solution).
| NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
|---|---|---|---|---|---|---|
| 69374-946-34 | Labetalol Hydrochloride 5 Mg/ml | Labetalol Hydrochloride Injection 5 Mg/ml | 30 VIAL, PLASTIC in 1 CARTON > 4 mL in 1 VIAL, PLASTIC | Injection, Solution | Intravenous | Nephron Sterile Compounding Center, Llc |
| 69374-946-34 | Labetalol Hydrochloride 5mg/ml | Labetalol Hydrochloride Injection 5mg/ml | 30 VIAL, PLASTIC in 1 CARTON > 4 mL in 1 VIAL, PLASTIC | Injection, Solution | Intravenous | Nephron Sterile Compounding Center, Llc |
Frequently Asked Questions
What is the NDC number assigned to Labetalol Hydrochloride 5mg/ml?
Labetalol Hydrochloride 5mg/ml was assigned by its manufacturer with NDC product code 82396-141. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Labetalol Hydrochloride 5mg/ml?
The NDC package code 82396-141-05 was assigned to a 5 mL in 1 SYRINGE, PLASTIC of labetalol hydrochloride administered intravenous via injection, solution.
Who manufactures this product?
Labetalol Hydrochloride 5mg/ml is manufactured by an outsourced facility and labeled by Annovex Pharma, Inc.. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 2 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Nephron Sterile Compounding Center, LLC with NDC product codes 69374-946-34 and 69374-946-34.